Last reviewed · How we verify

NCT04653116: FIM-ASP-20201

Clinical Management in Asthmatic Patients Attended in the Influential Area of Hospital Universitario Virgen de la Victoria, Málaga

Status unknown Last updated 4 December 2020
What this trial tests

trial in Asthma in 300 participants. Status unknown.

Timeline
1 November 2020
Primary endpoint
29 November 2020
30 June 2021

Quick facts

Lead sponsorFundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment300
Start date1 November 2020
Primary completion29 November 2020
Estimated completion30 June 2021
Sites1 location across Spain

Conditions studied

Sponsor

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud — full company profile →

Who can join

Adults 18 to 80, any sex, with Asthma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This evidence raises the need to determine the assistance quality care in asthma population in the influential area of Hospital Universitario Virgen de la Victoria through the assistance quality care indicators established by GEMA guidelines. The aim of this study is to obtain clinical data that allow to assess assistance quality degree in order to find improvement opportunities to achieve a better control of asthmatic patients within this influential area.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Asthma

Currently open trials in the same condition.

Other Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04653116.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing